Thomas G. Schulze
 |
Professor Thomas G. Schulze, born in 1969, studied medicine in Germany, the USA, and Catalonia. He trained as a psychiatrist and held positions in Germany (Bonn, Mannheim, Göttingen) and the USA (Chicago, Bethesda, Baltimore). Since 2014, he has held the position of Chair and Director of the Institute of Psychiatric Phenomics and Genomics at the Ludwig-Maximilans-University of Munich (IPPG). He is also on Faculty at Johns Hopkins University’s Department of Psychiatry. |
|
Dr. Schulze’s research focuses on genotype-phenotype relationship in psychiatric disorders. He coordinates a German-wide center grant on longitudinal psychosis research (www.kfo241.de; www.PsyCourse.de) and spearheads an international study on the genetic basis of response to lithium treatment in bipolar disorder (www.ConLiGen.org), comprising several research groups from Europe, the Americas, Asia, and Australia. He has authored over 200 papers. In addition to national German awards, he is the 2006 recipient of the Robins-Guze-Award of the American Psychopathological Association (APPA), the 2006 recipient of the Theodore-Reich-Award of the International Society of Psychiatric Genetics (ISPG), and the winner of the Colvin Prize 2016 of the Brain & Behavioral Research Foundation (BBRF). He is a member of the American College of Neuropsychopharmacology, and served as the President of the APPA from 2015 through 2016. Since 2016, he has also held the office of President of the ISPG. From 2011 through 2017, he served as the Chair of the Section on Psychiatric Genetic of the World Psychiatric Association (WPA), which he is an Honorary Member of. In 2017, he was elected to the Executive Committee of the WPA, starting a 6-year term as Secretary of Scientific Sections. |
|
